In 2025, large language models moved beyond benchmarks to efficiency, reliability, and integration, reshaping how AI is ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...